5,6,8,14-Tetradehydro-3-hydroxy-2,6-dimethoxymorphinan-7-one (19777-83-4)
Identification |
Properties |
Safety Data |
|
|
Other Product
- (9α,13α)-5,6,8,14-Tetradehydro-2-hydroxy-3,6-dimethoxymorphinan-7-one
- 5,6-Didehydro-4-hydroxy-3,6-dimethoxymorphinan-7-one
- 7-hydroxy-14-azadispiro[5.1.58.26]pentadecan-15-one
- Benzo[3,4]-18-norandrosta-3,12,15-trien-17- one,6'-ethyl-1',2',3',4',5',6'-hexahydro-7- hydroxy-4,6',8-trimethyl-,(3â,4R,6'R,7â,8R,9â,- 10R,14â)-
- (6S,9S,13S)-8,14-Didehydro-4-(benzyloxy)-17-[(benzyloxy)carbonyl]-6-[(tert-butyldimethylsilyl)oxy]-3,8-dimethoxymorphinan-7-one
- 5,6,8,14-Tetradehydro-3-hydroxy-2,6-dimethoxy-17-methylmorphinan-7-one
- 1',3'a,4',5',5'a,6',7',8',8'a,8'b-Decahydro-6'-hydroxy-1,4,5'a-trimethylspiro[bicyclo[3.1.0]hexane-6,3'(2'H)-as-indacen]-2-one 6'-acetate
- Pyrido[2,3-b]pyrazin-6(5H)-one,8-hydroxy-7-(3-methyl-2-butenyl)-5-phenyl-
- 1/C11H7ClO2/c12-9-3-1-2-8(6-9)11-5-4-10(7-13)14-11/h1-7
- 7-(2-hydroxyethoxy)-14-azadispiro[5.1.58.26]pentadecan-15-one
- 1/C15H22O3/c1-9-10(2)14-12(11(3)13(9)17)5-6-15(4,18-14)7-8-16/h16-17H,5-8H2,1-4H
- 1/C12H24O2Te/c1-14-12(13)10-8-6-4-3-5-7-9-11-15-2/h3-11H2,1-2H
- 1/C7H10N3O3P/c1-4-7-13-9-5(2)14(7,12)10(8-4)6(3)11/h7H,1-3H
- 1/C15H13NO/c1-2-16-14-6-4-3-5-12(14)13-9-11(10-17)7-8-15(13)16/h3-10H,2H2,1H
- 1/C14H12NS/c1-2-6-12(7-3-1)10-15-11-16-14-9-5-4-8-13(14)15/h1-9,11H,10H2/q+
- 1/C14H19NO2/c1-3-12-10-17-9-8-15(12)14-7-5-4-6-13(14)11(2)16/h4-7,12H,3,8-10H2,1-2H
- 1/C13H15NO2/c15-8-10-7-9-3-1-5-14-6-2-4-11(12(9)14)13(10)16/h7-8,16H,1-6H
- 1/C14H9Br2O2P/c15-11-6-8-13(17-11)19(10-4-2-1-3-5-10)14-9-7-12(16)18-14/h1-9
- 1/C14H15O3P/c15-18(16-11-13-7-3-1-4-8-13)17-12-14-9-5-2-6-10-14/h1-10,18H,11-12H
- 1/C11H9N5O/c1-17-6-2-3-8-9(4-6)16-11(14-8)7(5-12)10(13)15-16/h2-4,14H,1H3,(H2,13,15